Our results also reveal that apelin enhances PI3K and Akt phosphorylation, which was antagonized by the c-Src inhibitor, suggesting that c-Src-dependent PI3K/Akt activation mediates apelin-controlled TIMP2 synthesis and the metastasis of human prostate cancer cells. Here, APLN is linked to prostate carcinoma.